Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
>
Issue Archive
> April 2008 Issue of MMM
April 2008 43 4 Issue of MMM
Editor's Desk
Change the channel on DTC
This is the time of year when we take our annual, in-depth look at direct-to-consumer advertising.
Features
DTC Report: Steady Migration
Slowly but surely, consumer advertising and promotion is getting smarter and more targeted as marketers broaden their media plans to cope with a dearth of ...
Navigating Restricted Waters
What's the difference between regulations, codes, guidelines and rules? Linda Klein defines the terminology, and examines the regulatory challenges facing the industry in the next ...
Rule of the Tool
To the person who only has a screwdriver, every task looks like it can be completed using that screwdriver, even when it's clearly the wrong ...
Heavyweights Fall Hard
With advertising expenditures continuing on a steady decline, there is no end to the suffering of medical/surgical journals—especially the biggest players. PERQ/HCI's Eugene M. May ...
Headliner: Genentech's Len Kanavy
Genentech VP, commercial operations, Len Kanavy was surprised, humbled and honored to receive this year's honorable mentor award from Healthcare Businesswomen's Association.
Antidote
Antidote
I have an expression that I like to use when describing a drug's fall from grace—I call it going from panacea to panic.
In Focus
Reprints draft guidance no gift to industry
Sales reps could be effectively barred from circulating journal article reprints discussing off-label uses under FDA's draft guidance on "Good reprint practices," and the agency ...
Med Ed Report
MA Senate proposes outright gift ban
The leader of the Massachusetts State Senate has proposed legislation banning all gifts to doctors from pharmaceutical companies.
J&J opens its Diabetes Institute in US
Johnson & Johnson in March cut the ribbon on its J&J Diabetes Institute, a dedicated facility on its Silicon Valley LifeScan campus for schooling healthcare ...
New site educates about Peyronie's
In an effort to educate physicians and consumers about a complex and painful form of erectile dysfunction know as Peyronie's disease, Cook Medical has launched ...
Professional Media
Haymarket takes over oncology titles
Haymarket Medical has taken over the operations of two US HealthCare Communications oncology titles—The American Journal of Hematology/Oncology and Oncology Nursing News.
Wolters Kluwer revenue down
Wolters Kluwer reported 2007 revenues for its health division down to 761 million Euros from 823 million Euros in 2006 and operating profits down to ...
Elsevier to acquire Windhover Information
Elsevier is acquiring Windhover Information, publisher of IN VIVIO and the RPM Report.
Advanstar names Stefany publisher
Advanstar named Rick Stefany publisher on Drug Topics.
Compact Clinicals acquired by Jones and Bartlett Publishers
Jones and Bartlett Publisher acquired Company Clinicals
Media Forum
Newspaper's nosedive not a surprise
For the first three quarters of 2007, pharmaceutical firms' spending on newspaper advertising plummeted, to $57 million from $84 million for the same period in ...
E-marketing
Web Watch
Remember the information superhighway?
Google's health offering to store medical records
Google unveiled its new online health service at a meeting of the Healthcare Management and Information Systems Society (HIMSS) in February.
HLTH Corp. to merge with WebMD
HLTH Corporation announced plans to merge with its WebMD Health subsidiary in a move that could make the combined company an attractive takeover target for ...
Direct Marketing
Shire hits the road to educate on UC
Shire Pharmaceuticals is hitting "the road" as part of a new unbranded education campaign for patients with ulcerative colitis (UC), complete with live events in ...
Botox 'off-label' promotion questioned
Allergan said it has received a subpoena for documents related to the promotion of Botox.
Endo, Novartis begin agreement
Endo Pharmaceuticals has entered into a licensing agreement with Novartis to obtain the exclusive US marketing rights for Voltaren Gel (diclofenac sodium topical gel) 1%.
DTC Report
Pfizer cans Lipitor ads, vowing 'clarity'
Pfizer pulled Lipitor ads featuring Dr. Robert Jarvik and vowed that it is "committing to ensuring greater clarity in the roles and responsibilities of its ...
Memorable ads in '07 a tale of bee and beaver
Ads featuring an animated bee and a talking beaver were the TV drug spots most recalled by consumers during 2007, according to advertising performance tracking ...
Rx drug ads prompt 1/3 of Americans to request drugs
Rx drug ads prompt nearly a third of Americans to ask their doctor about an advertised drug, and of those who ask, 82% get a ...
Analysts: Sepracor decrease could mean cut in DTC
Sepracor said in reporting Q4 2007 results, 2008 revenues projected to be spent on sales, marketing and distribution expenses would likely decrease around 10% compared ...
Jarvik berates NY Times in letter
Dr. Robert Jarvik berated The New York Times in a March 3 letter for calling him a "pitchman" rather than a "spokesman."
Public Relations
PR View by Ann Moravick
Go online and you'll see bountiful commentary about drug companies and their products.
Centocor joins its parent company in blogosphere
Centocor launched itself into the blogosphere with the debut of its corporate blog at cnto411.com.
PhRMA strikes a more conciliatory note
DTC ads can be "both a blessing and a curse," and if companies fail to include messaging about patient assistance programs in them, "then your ...
Marketing Research
Vantage Point
I'll bet that if you hear one more person in our industry talk about the pressure being applied on marketing researchers to do more with ...
Pharma wants partners not just data suppliers
Form true partnerships with your clients, keep them happy and make your recommendations short and sweet—that's the message from pharma companies to their marketing research ...
Washington Insider
As I see it
As the Bush administration prepares to eke out its last months in office, there is a sense of urgency that it should leave a judicially ...
Attorneys: Scientific free speech 'threatened'
Attorneys Arnold Friede and Robert Nicholas (both McDermott, Will & Emery) say calls for an investigation into support for the American Heart Association (AHA) and ...
Stupak calls for agency chief to resign
In a sign that Capitol Hill is losing patience with the FDA's oversight of the nation's drug supply, House Energy and Commerce oversight and investigations ...
FDA, NIH collaborate on AE reporting
The FDA and the NIH have agreed to develop a harmonized adverse event (AE) reporting mechanism for consumers, health professionals, investigators, sponsors and other parties ...
Enforcement changes in new FDA law
A prominent Washington food and drug lawyer has warned the industry that three new civil money penalty provisions were added without fanfare to the Federal ...
Attorneys: PDMA isn't broken, don't change it
Two Hyman, Phelps & McNamara attorneys have told the US Sentencing Commission that the guideline for misdemeanor offenses under the Prescription Drug Marketing Act isn't ...
Conflicts of interest 'rampant' in medical device industry
A staff investigation at the Senate Special Committee on Aging has found that conflicts of interest are rampant in the medical device industry.
Leavitt: foreign companies deny access for US officials
HHS secretary Michael Leavitt says foreign companies can often deny US officials access to their facilities without adverse consequences.
Investigator to Congress: Ketek data was known to be fraudulent
A subpoenaed FDA criminal investigator has told Congress that Aventis should have known that data it submitted to support the approval of antibiotic Ketek was ...
Back Talk
The un-empowered patient
It's become part of received wisdom that today's patient is an active partner in his or her medical care. Since we all accept this as ...
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
Pharmas are from Mars, Payers are from Venus
No-see docs are know-nothings when it comes to new drug info, study suggests
Study: Young Latinas are key decision makers, prefer English
How CDC's hep.-C testing advice benefits drugmakers now
Coach vs. cancer in BMS-backed awareness effort
Harvard urges faculty to ditch journals
Study: Young Latinas are key decision makers, prefer English
Pharma Report 2012: Get Back in Shape
Massachusetts gift ban under attack (again)
Pfizer, Crestor tops for global promotional spend in 2011
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Med Ed Report: Show Me the Money
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Bydureon catching on among endos but low profits expected, Amylin says
Did FDA's Vytorin warning negatively impact health outcomes?
Roundtable outlines path for publisher, pharma credibility
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Popular Topics
Acquisition
Adherence
App
Celebrity
Clinical Trial
Co-Marketing
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Medical Journal
Mobile
Sales Force